Edgestream Partners’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-898	Closed	-$311K	–	851
2024 Q1	$311K	Sell	898 -8,134	-90%	-$2.67M	0.02%	719
2023 Q4	$2.92M	Buy	9,032 +3,754	+71%	+$1.18M	0.21%	144
2023 Q3	$1.89M	Buy	+5,278	New	+$2.04M	0.15%	209
2023 Q2	–	Sell	-762	Closed	-$365K	–	723
2023 Q1	$365K	Buy	+762	New	+$357K	0.04%	447
2022 Q4	–	Sell	-8,660	Closed	-$3.61M	–	509
2022 Q3	$3.61M	Buy	8,660 +6,857	+380%	+$3.42M	0.28%	129
2022 Q2	$892K	Buy	+1,803	New	+$939K	0.07%	343
2021 Q3	–	Sell	-499	Closed	-$322K	–	493
2021 Q2	$322K	Sell	499 -7,526	-94%	-$4.58M	0.02%	388
2021 Q1	$4.58M	Buy	+8,025	New	+$4.75M	0.26%	149